JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M705265200 on July 23, 2007

J. Biol. Chem., Vol. 282, Issue 41, 30150-30160, October 12, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow An addition or correction has been published
Right arrow All Versions of this Article:
282/41/30150    most recent
M705265200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Young, J. E.
Right arrow Articles by Ellerby, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Young, J. E.
Right arrow Articles by Ellerby, L. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Proteolytic Cleavage of Ataxin-7 by Caspase-7 Modulates Cellular Toxicity and Transcriptional Dysregulation*Formula

Jessica E. Young{ddagger}, Launce Gouw§, Stephanie Propp{ddagger}, Bryce L. Sopher, Jillian Taylor||, Amy Lin{ddagger}, Evan Hermel**, Anna Logvinova{ddagger}, Sylvia F. Chen{ddagger}, Shiming Chen{ddagger}{ddagger}, Dale E. Bredesen{ddagger}§, Ray Truant||, Louis J. Ptacek§1, Albert R. La Spada2, and Lisa M. Ellerby{ddagger}3

From the {ddagger}Buck Institute for Age Research, Novato, California, 94945, §Department of Neurology, Howard Hughes Medical Institute, University of California, San Francisco, California 94143, Departments of Laboratory Medicine, Medicine (Medical Genetics), and Neurology (Neurogenetics), University of Washington Medical Center, Seattle, Washington 98195, ||McMaster University, Department of Biochemistry and Biomedical Sciences, Hamilton, Ontario L8N 3Z5, Canada, **Touro University College of Osteopathic Medicine, Vallejo, California 94592, and {ddagger}{ddagger}Department of Ophthalmology and Visual Sciences, Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, Missouri 63110

Spinocerebellar ataxia type 7 (SCA7) is a polyglutamine (polyQ) disorder characterized by specific degeneration of cerebellar, brainstem, and retinal neurons. Although they share little sequence homology, proteins implicated in polyQ disorders have common properties beyond their characteristic polyQ tract. These include the production of proteolytic fragments, nuclear accumulation, and processing by caspases. Here we report that ataxin-7 is cleaved by caspase-7, and we map two putative caspase-7 cleavage sites to Asp residues at positions 266 and 344 of the ataxin-7 protein. Site-directed mutagenesis of these two caspase-7 cleavage sites in the polyQ-expanded form of ataxin-7 produces an ataxin-7 D266N/D344N protein that is resistant to caspase cleavage. Although ataxin-7 displays toxicity, forms nuclear aggregates, and represses transcription in human embryonic kidney 293T cells in a polyQ length-dependent manner, expression of the non-cleavable D266N/D344N form of polyQ-expanded ataxin-7 attenuated cell death, aggregate formation, and transcriptional interference. Expression of the caspase-7 truncation product of ataxin-7-69Q or -92Q, which removes the putative nuclear export signal and nuclear localization signals of ataxin-7, showed increased cellular toxicity. We also detected N-terminal polyQ-expanded ataxin-7 cleavage products in SCA7 transgenic mice similar in size to those generated by caspase-7 cleavage. In a SCA7 transgenic mouse model, recruitment of caspase-7 into the nucleus by polyQ-expanded ataxin-7 correlated with its activation. Our results, thus, suggest that proteolytic processing of ataxin-7 by caspase-7 may contribute to SCA7 disease pathogenesis.


Received for publication, June 27, 2007

* This work is supported by National Institutes of Health Grants NS40251A (to L. M. E.) and EY14061 (to A. R. L.) and Operating Grant MOP 36518 and a New Scientist Award from the Canadian Institutes of Health Research (to R. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. 1-3.

1 An Investigator of the Howard Hughes Medical Institute.

2 A Paul Beeson Physician Faculty Scholar recipient from the American Federation of Aging Research.

3 To whom the correspondence should be addressed: The Buck Institute for Age Research, 8001 Redwood Blvd, Novato, CA 94945. Tel.: 415-209-2088; Fax: 415-209-2230; E-mail: lellerby{at}buckinstitute.org.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
S. C. Warby, C. N. Doty, R. K. Graham, J. B. Carroll, Y.-Z. Yang, R. R. Singaraja, C. M. Overall, and M. R. Hayden
Activated caspase-6 and caspase-6-cleaved fragments of huntingtin specifically colocalize in the nucleus
Hum. Mol. Genet., August 1, 2008; 17(15): 2390 - 2404.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.